The Tamil Nadu-based SRM University will float a pharmaceutical company styled SRM Pharma Ltd under which it will sell a new diabetes drug that the University’s faculty researchers have discovered.
The university today announced that it has received a US patent for the drug used for the treatment and management of Type-II Diabetes mellitus.
“A team of faculty researchers comprising Govind Prasad Dubey, Aruna Agrawal, Nirupama Dubey, Shipra Dubey, Rajesh Dubey, Samamtsan Mercy Deborah succeeded in getting the patent after a lot of active research and the patent is assigned to SRM University as per the US Patent Office Web site,” says a press release from the University.
The Vice-Chancellor of the University M. Ponnavaikko said the University would launch the drug in about six months. “We can get the drug manufactured from a unit in North India,” he said.
The university has filed two more inventions for patents with the US patent office.
“We will shortly file patent applications for two more herbal drugs for menopause, cardiovascular and obesity problems,” he said.
Type-II Diabetes mellitus (DM) is a metabolic disorder that is primarily characterised by insulin resistance, relative insulin deficiency and hyperglycemia. It is rapidly increasing in the developed countries and there is also evidence that this pattern will be followed in much of the rest of the world in the coming years.